Xarelto is a blood thinning medication currently at the center of a series of lawsuits. The suits allege that the drug’s makers did not adequately warn the public of the very serious and dangerous side effects linked to the product.
Recently, federal judges in Louisiana and Pennsylvania gathered the many Xarelto lawsuits into a multidistrict litigation and a mass tort program. There are well over a hundred lawsuits filed by the people negatively affected by the drug and the inclusion in an MDL and mass tort program is an attempt to streamline the process and make things more efficient for each plaintiff.
Recently one of the judges involved in the lawsuits – Judge Eldon Fallon – appointed Andy Birchfield and Brian Barr as the heads of the Plaintiffs’ Steering Committee. The 12 member committee will work to make sure the cases all move along efficiently from the discovery process through to trial team selection, if it comes to that.
There is a chance that the cases will be settled before a trial takes place. If that is the case, the steering committee – headed by the co-lead counsels of the cases – will be charged with ensuring the process of looking at settlement options is as swift and efficient as possible.
Approximately a third of the Xarelto lawsuits filed in the United States are part of an MDL. Other lawyers who are also on the Xarelto Litigation Plaintiff’s steering committee include:
- Ellen Relkin
- Bradley Honnald
- Frederick Longer
- Russel Abney
- Dianne Nast
- Roger Denton
- Sindhu Daniel
- Michael Goetz
- Neil Overholtz